Eli Lilly and Company LLY Analyst Ratings

6 ratings from Wall Street analysts · Consensus as of Aug 19, 2026

Analyst Ratings
Buy Avg target $1300 showing 6 ratings
Consensus is Buy with a $1,300 average target across 28 analysts (S&P Global, as of 19 August 2026), on a range of $850 to $1,600. Rows below are the most recent sourced analyst actions, via stockanalysis.com. Consensus as of Aug 19, 2026
LLY
Reiterated
2026-08-17
Barclays
RatingOverweight
From—
Target$1,400
From—
Reiterated
2026-08-14
Berenberg Bank
RatingHold
From—
Target$1,135
From—
Reiterated
2026-08-11
Truist Financial
RatingBuy
From—
Target$1,376
From—
Reiterated
2026-08-06
Bernstein
RatingOutperform
From—
Target$1,385
From—
Reiterated
2026-08-06
Goldman Sachs
RatingBuy
From—
Target$1,283
From—
Reiterated
2026-08-06
Cantor Fitzgerald
RatingOverweight
From—
Target$1,350
From—